Enable AccessibilityEnable Accessibility

Areas of Focus

Our R&D efforts are focused on four therapeutic areas: Oncology, Rare Diseases, Neuroscience, and Gastroenterology (GI). We also make targeted R&D investments in Plasma-Derived Therapies and Vaccines.


We endeavor to deliver novel medicines to patients with cancer worldwide through our commitment to science, breakthrough innovation and passion for improving the lives of patients. This singular focus drives our aspirations to discover, develop, and deliver breakthrough oncology therapies.
Please visit here for more information

Rare Diseases

Takeda aspires to transform the treatment of rare diseases in immunology, hematology, metabolic and lysosomal storage disorders.



Our neuroscience therapeutic area is driven by the immense unmet need of patients with diseases of the central nervous system. Our mission is to bring innovative medicines to patients suffering from neurologic and psychiatric diseases for whom there are no treatments available.



Gastrointestinal (GI) diseases can be complex, debilitating, and life-changing. For more than 25 years, Takeda and our collaboration partners have focused on improving the lives of patients through the delivery of innovative medicines and dedicated patient disease support programs


Plasma-Derived Therapies

Plasma-derived therapies are critical, life-saving medicines that thousands of people with rare and complex diseases rely on every day around the world.
Global demand for these therapies, particularly immunoglobulins, has increased dramatically over the last 15 years, and continues to grow.



Vaccines have transformed global public health. Our world-class vaccine team is addressing unmet medical needs through vaccine development against infectious diseases, and at the same time using innovative development platforms and collaborating with leading partners. 
Please visit here for more information

Related Content